Intratumoral metabolic heterogeneity can predict disease progression after cancurrent chemoradiotherapy in patients with inoperable stage III non-small cell lung cancer > 학술발표

본문 바로가기

연구성과

서브비주얼

학술발표

2012 Intratumoral metabolic heterogeneity can predict disease progression a…

게시글 작성정보

profile_image
  • 작성자 분자영상테라노스틱스연구소
  • 작성일 17-12-19 11:25
  • 조회수 1
  • 댓글수 0

게시글 본문

기본정보

기본정보
학회명 제 51차 대한핵의학회 추계학술대회
발표제목 Intratumoral metabolic heterogeneity can predict disease progression after cancurrent chemoradiotherapy in patients with inoperable stage III non-small cell lung cancer
발표자 Sae-Ryung Kang, Ho-Chun Song, Byung Hyun Byun, Jong-Ryool Oh, Jahae Kim, Su Woong Yoo, Sang-Geon Cho, Hee Jeong Park, Jung-Joon Min, Hee-Seung Bom 10명
Intratumoral metabolic heterogeneity can predict disease progression after cancurrent chemoradiotherapy in patients with inoperable stage III non-small cell lung cancer